0.38
-0.0242(-5.99%)
Currency In USD
| Previous Close | 0.4 |
| Open | 0.41 |
| Day High | 0.42 |
| Day Low | 0.38 |
| 52-Week High | 20.6 |
| 52-Week Low | 0.35 |
| Volume | 323,200 |
| Average Volume | 8.36M |
| Market Cap | 8.33M |
| PE | -0.07 |
| EPS | -5.64 |
| Moving Average 50 Days | 0.6 |
| Moving Average 200 Days | 4.38 |
| Change | -0.02 |
If you invested $1000 in KALA BIO, Inc. (KALA) since IPO date, it would be worth $0.41 as of February 21, 2026 at a share price of $0.38. Whereas If you bought $1000 worth of KALA BIO, Inc. (KALA) shares 5 years ago, it would be worth $0.82 as of February 21, 2026 at a share price of $0.38.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
KALA BIO Settles Approximately $10.6 million of Debt
GlobeNewswire Inc.
Jan 05, 2026 9:10 PM GMT
ARLINGTON, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), (“KALA” or the “Company”) today announced the successful completion of its loan settlement with Oxford Finance, LLC (“Oxford”), marking a transformational milestone f
KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
GlobeNewswire Inc.
Dec 05, 2025 7:36 PM GMT
ARLINGTON, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
GlobeNewswire Inc.
Dec 04, 2025 3:45 PM GMT
ARLINGTON, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced that it has entered into definitive agreements for the purchase of an aggregate of 10,000,000 shares of its common stock (or